UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Income Statement [Abstract] | ||||
| Revenues, net | $ 73,424,719 | $ 80,417,622 | $ 148,975,203 | $ 176,450,677 |
| Expenses: | ||||
| Cost of revenues (exclusive of depreciation and amortization, which is shown separately below) | 51,018,120 | 54,998,524 | 102,685,708 | 120,183,584 |
| Operating expenses: | ||||
| General and administrative | 29,742,190 | 31,240,943 | 60,577,258 | 64,143,013 |
| Depreciation and amortization | 2,691,411 | 3,981,008 | 5,338,518 | 7,742,399 |
| Legal and regulatory | 4,025,638 | 4,351,974 | 9,059,768 | 8,562,797 |
| Technology and development | 3,446,289 | 2,957,203 | 7,151,338 | 6,596,647 |
| Sales, advertising and marketing | 423,294 | 368,214 | 795,927 | 699,919 |
| Total expenses | 91,346,942 | 97,897,866 | 185,608,517 | 207,928,359 |
| Income (loss) from operations | (17,922,223) | (17,480,244) | (36,633,314) | (31,477,682) |
| Other (expense) income: | ||||
| Interest expense, net | (97,583) | (443,662) | (197,315) | (869,946) |
| Loss on change in fair value of contingent consideration | 0 | 0 | (2,760,000) | 0 |
| Insurance proceeds | 0 | 0 | 4,687,798 | 0 |
| Loss on equity method investment | 0 | (38,817) | 0 | (79,515) |
| Loss on remeasurement of operating and finance leases | 0 | (6,607) | 0 | (47,444) |
| Loss on disposal of fixed assets | (39,574) | (48,354) | (102,067) | (33,215) |
| Other income (expense) | 123,211 | 101,046 | 388,175 | (211,823) |
| Total other (expense) income | (13,946) | (436,394) | 2,016,591 | (1,241,943) |
| Net loss before income tax (provision) benefit | (17,936,169) | (17,916,638) | (34,616,723) | (32,719,625) |
| (Provision for) benefit from income taxes | (56,129) | 4,626,745 | (75,412) | 8,350,432 |
| Net loss | (17,992,298) | (13,289,893) | (34,692,135) | (24,369,193) |
| Net loss attributable to noncontrolling interests | (2,172,021) | (2,134,647) | (4,108,727) | (3,808,632) |
| Net loss attributable to stockholders of DocGo Inc. and Subsidiaries | (15,820,277) | (11,155,246) | (30,583,408) | (20,560,561) |
| Other comprehensive (loss) income | ||||
| Unrealized (loss) gain on investments, net of tax | (54,965) | 76,733 | (126,869) | 76,733 |
| Foreign currency translation adjustment | (23,730) | 927,462 | (91,246) | 1,423,000 |
| Total comprehensive loss | $ (15,898,972) | $ (10,151,051) | $ (30,801,523) | $ (19,060,828) |
| Net loss per share attributable to DocGo Inc. and Subsidiaries - Basic (in dollars per share) | $ (0.16) | $ (0.11) | $ (0.31) | $ (0.21) |
| Weighted-average shares outstanding - Basic (in shares) | 98,802,810 | 98,931,293 | 98,774,609 | 100,255,877 |
| Net loss per share attributable to DocGo Inc. and Subsidiaries - Diluted (in dollars per share) | $ (0.16) | $ (0.11) | $ (0.31) | $ (0.21) |
| Weighted-average shares outstanding - Diluted (in shares) | 98,802,810 | 98,931,293 | 98,774,609 | 100,255,877 |
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. No definition available.
|
| X | ||||||||||
- Definition Expenses Abstract No definition available.
|
| X | ||||||||||
- Definition Gain (Loss) Remeasurement Of Operating and Finance Leases No definition available.
|
| X | ||||||||||
- Definition Amount of increase (decrease) in value of liability in contingent consideration arrangement in business combination, including, but not limited to, difference arising upon settlement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of other-than-temporary decline in value that has been recognized against investment accounted for under equity method of accounting. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount recovered from insurance. These recoveries reduce costs and losses that are reported as a separate line item under operating expenses. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of interest income (expense) classified as nonoperating. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|